Alnustone promotes hepatic stellate cell ferroptosis via the DNMT3A/GLS2/SLC7A11 axis
Liver fibrosis is a progressive pathological process driven by chronic liver injury, with hepatic stellate cell (HSC) activation as its core driver. Ferroptosis has been demonstrated to mediate HSC activation, and accumulating evidence indicates that GLS2 and DNMT3A play key regulatory roles in ferroptosis. Consequently, targeting ferroptosis has emerged as a promising therapeutic strategy. Alnustone, a natural diarylheptanoid, exhibits anti-fibrotic potential and hepatoprotective properties. Therefore, this study aimed to investigate the anti-fibrotic effects of alnustone and elucidate its underlying molecular mechanisms. The results revealed that alnustone significantly attenuated CCl 4 -induced liver fibrosis in mice, as evidenced by reduced serum liver injury markers, collagen deposition, and downregulated HSC activation markers (α-SMA, Col1A1). RNA-sequencing and functional experiments confirmed that alnustone induced HSC ferroptosis in vivo and in vitro, characterized by mitochondrial cristae loss and elevated ferroptosis hallmarks. The ferroptosis inhibitor ferrostatin-1 abrogated alnustone’s HSC-inactivating effects in vitro. Mechanistically, alnustone targeted and suppressed DNMT3A expression, promoting GLS2 demethylation and upregulation. Co-IP and molecular docking confirmed that GLS2 interacted with SLC7A11 to negatively regulate its expression, thereby facilitating HSC ferroptosis. In addition, DNMT3A overexpression reversed alnustone-induced GLS2 upregulation and ferroptosis. Silencing GLS2 suppressed alnustone-induced HSC ferroptosis and inactivation, whereas GLS2 overexpression alleviated liver fibrosis in HSC-specific GLS2-overexpression (GLS2 cKI ) mice after CCl 4 treatment. Collectively, alnustone alleviates liver fibrosis by inducing HSC ferroptosis through the DNMT3A/GLS2/SLC7A11 axis.
Authors
- Jianjian Zheng (ORCID: https://orcid.org/0000-0001-8770-4219)
- Boyu Lv (ORCID: https://orcid.org/0000-0001-9174-7887)
- Menglu Shu
- Mengting Shen
- Mengyuan Li
- Xiang Su
- Weizhi Zhang
Institutions
- First Affiliated Hospital of Wenzhou Medical University (CN)
- People's Hospital of Cangzhou (CN)
Publication Details
- Journal
- Cell Biology and Toxicology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s10565-026-10339-0
- Primary Topic
- Liver physiology and pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00